Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates. Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium. For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register. For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.
Patent details
2287192
Title:
Procédés de prévention et de traitement des métastases de cancer et perte osseuse associée aux métastases de cancer
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic information
Application number:
101782258
WO application number:
Type:
European patent granted for BE
Status:
Revoked
Publication number:
2287192
WO publication number:
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:
Dates
Filing date:
17/11/2003
Grant date:
26/08/2015
EP publication date:
23/02/2011
WO publication date:
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
26/08/2015
EP B1 publication date:
26/08/2015
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
17/11/2023
Revocation Date:
08/11/2018
Applicant
Name:
Novartis Vaccines and Diagnostics, Inc.
Legal Form:
From:
26/08/2015
Address:
Intellectual Property R338
P.O. Box 8097, Emeryville CA 94662-8097, United States (US)